Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-БІОКОМПЛЕКС is a liposomal dietary supplement developed and marketed by Biolik Biopharmaceutical, based in Kharkiv, Ukraine. The product is a combination of two active ingredients: L-carnitine and thioctic acid (alpha-lipoic acid), delivered in a liposomal formulation to enhance bioavailability. L-carnitine is a naturally occurring compound essential for energy metabolism, specifically facilitating the transport of long-chain fatty acids into the mitochondria for beta-oxidation. Thioctic acid serves as a potent antioxidant and a critical cofactor for mitochondrial enzyme complexes involved in glucose and lipid metabolism. L-БІОКОМПЛЕКС is marketed in Ukraine for the management of cardiovascular conditions, particularly chronic heart failure in patients with metabolic syndrome, where it aims to support myocardial energy production and mitigate oxidative stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on L-БІОКОМПЛЕКС.